| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.5 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.5 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |